GeneDx Holdings Corp. (NASDAQ:WGSWW – Get Free Report) was the target of a significant growth in short interest in March. As of March 13th, there was short interest totaling 13,901 shares, a growth of 262.0% from the February 26th total of 3,840 shares. Based on an average trading volume of 134,350 shares, the short-interest ratio is currently 0.1 days. Based on an average trading volume of 134,350 shares, the short-interest ratio is currently 0.1 days.
GeneDx Trading Down 27.8%
NASDAQ WGSWW opened at $0.01 on Wednesday. GeneDx has a 12 month low of $0.00 and a 12 month high of $0.25. The company’s 50 day simple moving average is $0.02 and its 200 day simple moving average is $0.05.
GeneDx Company Profile
GeneDx is a molecular diagnostics company specializing in high-complexity genetic testing for rare and ultra-rare inherited disorders. The company leverages next-generation sequencing (NGS) technologies, including whole exome sequencing, targeted gene panels, and chromosomal microarray analysis, to deliver comprehensive diagnostic insights. Its services are designed to support clinicians in identifying genetic mutations that underlie pediatric and adult conditions, guiding patient management, treatment decisions, and genetic counseling.
Founded in 2000 by Dr.
Featured Articles
Receive News & Ratings for GeneDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneDx and related companies with MarketBeat.com's FREE daily email newsletter.
